Olaregen Therapeutix

Olaregen Therapeutix is a regenerative medicine company focused on the development, manufacturing, and commercialization of products that address unmet needs in the current wound care market. The company aims to provide advanced therapeutic solutions that significantly improve medical outcomes while reducing overall care costs. Olaregen's first product, Excellagen (Flowable Dermal Matrix), is a topical application product for skin wounds and other indications. The company concentrates on advancing wound care, including diabetic foot ulcers (DFU), venous leg ulcers, and pressure ulcers. Its mission is to become a significant force in the field of regenerative medicine and to drive the advancement of rehabilitation science.